Close Menu
ABL Logo
Link to the Link to the Link to the

ABL advises InstantScripts on $135 million sale to Australian Pharmaceutical Industries

Corporate and M&A
iStock 1413603540 min v2

Arnold Bloch Leibler has advised medical prescriptions business, InstantScripts, on its agreement for 100% of the shares in the company to be acquired by Australian Pharmaceutical Industries, a wholly-owned subsidiary of Wesfarmers Limited, with a sale price of approximately $135 million.

InstantScripts, allows patients to obtain express medical scrips online for more than 300 medicines and gained interest from Wesfarmers as it looks to build out its health division.

Corporate and M&A partner Jeremy Leibler led the deal with the assistance of senior associates Gabriel Sakkal, Ari Bendet, lawyer Stephanie Aitken and law graduate Omer Samuni.

Congratulating InstantScripts on the sale, Jeremy Leibler said: "We look forward to seeing how this milestone transaction will shape the future of the digital health space."

Dr Asher Freilich, InstantScripts founder, said: “We’re incredibly proud of the business we’ve built at InstantScripts and the bright future it will have in Wesfarmers’ Health division."

Read next